medical treatment

Intensity-Modulated Radiation Therapy (IMRT) for Localized Prostate Cancer (Saito Yukoukai Hospital, Medical Corporation Yukoukai)

implementation facility

SAITO YUKOUKAI HOSPITAL

Facility Details

Lobby

Exterior view

Radiation Therapy Equipment

Lobby

Exterior view

Radiation Therapy Equipment

program name: Intensity-Modulated Radiation Therapy (IMRT) for Localized Prostate Cancer (Saito Yukoukai Hospital, Medical Corporation Yukoukai)

genre

medical treatment：radiation、cancer、prostate cancer

program details: By utilizing the advanced technology of Intensity-Modulated Radiation Therapy (IMRT), we deliver highly precise radiation treatment. This approach minimizes radiation exposure to surrounding healthy organs while administering a high dose to the prostate, achieving treatment outcomes comparable to, or even surpassing, those of surgery.

requirement, condition for apply: - No contraindications to radiation therapy, such as complications from collagen diseases (e.g., scleroderma) or hereditary disorders (e.g., xeroderma pigmentosum).
- Must have a trusted urologist in the patient’s home country to ensure follow-up care, including treatment efficacy evaluation and management of side effects after radiation.
- Must be able to stay in Japan for approximately 8 weeks, covering both the preparation and radiation periods, and be available for consultations during that time.
- Outpatient treatment must be feasible (hospitalization is not permitted).
- The patient must personally sign the consent forms for examinations and treatments issued by our clinic, and it is preferable to have an additional family member’s signature.
- No prior history of radiation therapy to the prostate or nearby areas.
- No pacemakers or internal metal implants, allowing for MRI examinations at our clinic.
- Must be able to maintain a supine position without movement for approximately 30 minutes.
- Diagnosed with prostate cancer through pathological examination based on more than 10 prostate biopsies, with a confirmed Gleason's score. The diagnostic report must be provided.
- Prostate imaging diagnosis performed with an MRI of 1.5 Tesla or higher, confirming localized prostate cancer (T-factor of T1-3 in the TNM classification). The imaging data and diagnostic report must be submitted.
- Imaging studies (CT, MRI, bone scintigraphy, FDG-PET/CT) must confirm no lymph node or distant metastasis (N0M0 in the TNM classification). The imaging data and diagnostic report must be submitted.
- Baseline PSA (iPSA) must have been measured, and the test report must be provided.
- It is preferable if hormone therapy (CAB therapy) has been administered for 6 to 12 months before the start of radiation therapy.
- Treatment may be declined if deemed inappropriate for our clinic.

precaution, contraindication: Radiation therapy cannot be provided if there is a history of prior radiation treatment to the prostate. Hospitalization for treatment is not permitted. Hormone therapy cannot be continued at our clinic during the radiation therapy period.

for more details information about this program,
kindly inquire from here

the facilities able to have this program